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"It is jurisprudentially inappropriate to disregard any relevant
evidence on any issue in any case, patent cases included."'
I. INTRODUCTION

It is a well-known proposition that foreign decisions relating to
patentability have no bearing on U.S. patentability. For this reason, the
prosecution history of a foreign patent may not be relevant to a patent
infringement suit of a counterpart U.S. patent. Despite its potential
irrelevance, some courts will admit evidence from a foreign prosecution
history during litigation of a counterpart U.S. patent. Courts generally
admit evidence from a foreign prosecution history in one of two contexts.
Such evidence is either admitted during claim construction or when a court
is considering the scope of equivalents available to a patentee.
This Article summarizes decisions in which the admissibility of
evidence from a foreign prosecution history was at issue during litigation
of a counterpart U.S. patent. Subsequently, it then discusses when the use
of a foreign prosecution history is appropriate during claim construction
and when it is appropriate during analysis under the doctrine of
equivalents, what components of the foreign prosecution history should be
used, and how much weight the evidence should be given. Specifically,
this Article discusses how evidence from a foreign prosecution history can
properly be used as extrinsic evidence, when necessary, during claim
construction and infringement analysis under the doctrine of equivalents.
II. BACKGROUND

Patents are generally territorial in nature in that a sovereign state grants
a patent and enforces that patent within the state's boundaries.2 The legal
standards of patentability vary from country to country, which means an
invention may be patentable in one country but not in another.3 These
1. Stratoflex, Inc. v. Aeroquip Corp., 713 F.2d 1530, 1538 (Fed. Cir. 1983).
2. See 35 U.S.C. § 271(a) (2004) ("[W]hoever without authority makes, uses, offers to sell,
or sells any patented invention, within the United States or imports into the United States any
patented invention during the term of the patent therefor, infringes the patent."), Christopher D.
DeCluitt, InternationalPatentProsecution,LitigationandEnforcement, 5 TULisAJ. COMP. & INT'L
L. 135, 136 (1997).
3. While all patent systems require novelty, obviousness or inventiveness, and utility or
industrial applicability, these requirements are defined differently from country to country.
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varying legal standards of patentability are typically referenced by U.S.
courts when finding that a judgment of patent validity in a foreign country
is irrelevant to the validity of a counterpart U.S. patent.4
These varying legal standards are also referenced in support of the
proposition that the prosecution history of a foreign patent should not be
admissible when litigating its counterpart U.S. patent under the doctrine
of equivalents or during claim construction. The reasoning behind this
argument is that the varying legal standards of patentability may make the
foreign prosecution history irrelevant to litigation of the U.S. patent
because the representations and amendments may have been made for a
reason irrelevant to U.S. patentability. 6 The statements may therefore be
prejudicial.7
Despite these concerns, courts have found it appropriate to admit
foreign prosecution histories for a variety of reasons. The cases generally
fall into one of two categories: a court allows the use of foreign
prosecution history during claim construction 8 or a court allows the use of
foreign prosecution history to estop a patentee from relying on the doctrine
of equivalents. 9 In all of these cases, the evidence considered from the

DeCluitt, supra note 2, at 138. For example, some countries require absolute novelty while others
require relative novelty. Id. at 139.
4. See, e.g., Medtronic, Inc. v. Daig Corp., 789 F.2d 903, 907-08 (Fed. Cir. 1986); In re
Dulberg, 472 F.2d 1394, 1398 (C.C.P.A. 1973); In re Guinot, 76 F.2d 134, 135-36 (C.C.P.A. 1935).
5. See, e.g., TI Group Auto. Sys., Inc. v. VDO N. Am., L.L.C., 375 F.3d 1126, 1136 (Fed.
Cir. 2004); Caterpillar Tractor Co. v. Berco, S.p.A., 714 F.2d 1110, 1116 (Fed. Cir. 1983); Mary
S. Consalvi, Objective IndiciaofEquivalenceand Nonequivalence-An Update, 573 PLI/PAT 171,
208 (1999); John R. Thomas, Litigation Beyond the Technological Frontier: Comparative
Approaches to MultinationalPatent Enforcement, 27 LAW & POL'Y INT'L Bus. 277, 310 (1996).
6. See Consalvi, supra note 5, at 208-09.
7. See id.
8. See generally, e.g., AK Steel Corp. v. Sollac & Ugine, 234 F. Supp. 2d 711, 770 (S.D.
Ohio 2002); Intellectual Prop. Dev., Inc. v. UA-Columbia Cablevision of Westchester, Inc., No.
94 CIV. 6296 (WHP), 2002 WL 10479, at *9 (S.D.N.Y. Jan. 3, 2002); Liposome Co. v. Vestar,
Inc., CIV.A.92-332-RRM, 1994 WL 738952 (D. Del. Dec. 20, 1994).
9. See generally, e.g., Tanabe Seiyaku Co. v. U.S. Int'l Trade Comm'n, 109 F.3d 726, 733
(Fed. Cir.), cert. denied, 522 U.S. 1027 (1997); CaterpillarTractorCo., 714 F.2d at 1116; Merck
& Co., Inc. v. Mylan Pharm., Inc., 19 F. Supp. 2d 334, 344 n. 17 (E.D. Pa. 1998); see also Rixon,
Inc. v. Racal-Milgo, Inc., 551 F. Supp. 163, 179 (D. Del. 1982) (noting that patentee was precluded
from resorting to an equivalent disclaimed in a communication to the German Patent Office during
an earlier patent suit in Kansas, but declining to hold the patent unenforceable for this conduct).
One court compelled production of a defendant's abandoned Dutch application in a patent
infringement suit despite the fact that the abandoned application would normally be confidential.
Ares-Serono, Inc. v. Organon Int'l B.V., 160 F.R.D. 1, *4 (D. Mass. 1994). The abandoned
application was directed to the same biologically active human fertility follicle stimulating hormone
that was at issue in the U.S. patent infringement suit. Id. at *3-*4. The district court found that the
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foreign prosecution history was limited to representations made by the
patentee to the foreign patent office. Claim amendments made during
foreign patent prosecution have not been considered in either context.
Although courts allow such evidence, the effect of its admission is
limited by the existing U.S. law regarding claim construction and
prosecution history estoppel. While representations made to foreign patent
offices have been admitted and even considered by courts, they have not
been used to contradict the ordinary meaning of a claim term during claim
construction, nor used as the sole basis for limiting the scope of
equivalents available to a patentee. To date, no patent infringement case
has turned upon the use of a counterpart patent's foreign prosecution
history.
II. USE OF FOREIGN PROSECUTION HISTORY DURING U.S. LITIGATION

A. ForeignProsecutionHistory and Claim Construction
Several courts have allowed the use of representations made during
prosecution of a foreign patent to aid in the claim construction of a
counterpart U.S. patent. The use of these representations is usually
justified because the representations provide insight into how a person of
ordinary skill in the art would view the claim term at issue.
1. Claim Construction
Determining whether a patent is infringed is a two-step process.10 The
first step is claim construction, or determining the meaning and scope of
the patent claims. 1" Claim construction is a matter of law.' 2 The second
step is comparing the properly construed claims to the device accused of
infringement. 3 This is a question of fact for the jury.'4

Dutch application was "arguably relevant." Id. at *4. It applied a balancing test and found that the
necessity for disclosure outweighed the desirability of maintaining the secrecy of the material in
the prosecution history, particularly given the protective order existing in the case. Id. However,
the fact that the defendants waived confidentiality by allowing the plaintiffs to view the document
was more critical than the relevance of the application. Id.
10. Markman v. Westview Instruments, Inc., 517 U.S. 370, 384 (1996).
11. Id.
12. Id. at 384, 391.
13. Id. at 384.
14. Id.
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Claim construction begins with an examination of the words of the
claims.1 5 There is a strong presumption that the claim terms maintain their6
ordinary meaning as viewed by one of ordinary skill in the art.'
Dictionary definitions may be consulted to establish a claim term's
ordinary meaning.' 7 Words in a claim maintain their ordinary meaning
unless a patentee chooses to be her own lexicographer and uses the terms
in a manner other than their ordinary meaning.18 In this case, the definition
of the term must be clearly stated in the patent specification or in the
prosecution history."' Not only is the specification used to determine
whether the patentee assigned a meaning to a term other than its ordinary
meaning, but it is also relevant to the claim construction analysis. 20 The
prosecution history may also be used to aid in claim construction after
consideration of ordinary meaning and specification. 2 '
A court may consider extrinsic evidence in addition to the intrinsic
evidence of the claims, specification, and prosecution history. 22 It is
appropriate, and sometimes "preferable," for a court to consult reliable
extrinsic evidence to determine whether a potential claim construction is
veering away from "clearly expressed, plainly apposite, and widely held
understandings in the pertinent technical field., 23 Extrinsic evidence may
be useful to aid the judge in interpreting the claims from the viewpoint of
one skilled in the art.24 Reliance on extrinsic evidence, however, is
improper unless the meaning of the claim terms remains ambiguous after
consideration of the intrinsic evidence.25 If the meaning of the terms is
clear and unambiguous, extrinsic
evidence may not be used to vary or
26
contradict that clear meaning.
Thus, there is a clear order to the claim construction process that
prioritizes intrinsic evidence. First, the words of the claims are given their
ordinary meaning as viewed by one of ordinary skill in the art, unless the
patentee has otherwise clearly defined the terms in the specification or

15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.

Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed. Cir. 1996).
Texas Digital Sys., Inc. v. Telegenix, Inc., 308 F.3d 1193, 1202 (Fed. Cir. 2002).
Id.
Vitronics, 90 F.3d at 1582.
Id.
Id.
id.
Pitney Bowes, Inc. v. Hewlett-Packard Co., 182 F.3d 1298, 1308 (Fed. Cir. 1999).
Id. at 1309.
Id.
Vitronics, 90 F.3d at 1583.
Id.
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prosecution history.27 The specification must be considered for this
analysis. 28 The prosecution history may also be considered after the
specification. 29 Finally, extrinsic evidence may be considered to determine
if the proposed claim construction is consistent with the understanding of
one of skill in the art. 30 The extrinsic evidence may not vary the meaning
unless the meaning is ambiguous after considering the intrinsic evidence.31
2. Decisions in Which Evidence from a Foreign Prosecution History
was Admitted to Aid in Claim Construction
In Liposome Co. v. Vestar, Inc., the District of Delaware allowed the
use of representations made to a foreign patent office during claim
construction.32 The Liposome Co. (TLC) sued Vestar, Inc. (Vestar) for
infringement of U.S. Patent No. 4,880,365, a process for the dehydration
of a colloidal dispersion of liposomes.33 One of the claim terms at issue
during claim construction was "mixing a hydrophilic compound with the
colloidal dispersion of the liposomes. ' 34 Vestar asserted that it did not
infringe the patent because it did not mix a hydrophilic solution with
liposomes but rather mixed a hydrophilic compound with lipids and
amphotericin B at the time it formed the liposomes. 35 During the claim
construction phase, TLC argued that "mixing" should be construed as
including adding liposomes to a hydrophilic compound, or adding a
hydrophilic compound to liposomes, or making liposomes in a hydrophilic
compound, as long as there was a mixture prior to dehydration.36
Vestar sought a claim construction of the word "mixing" that meant the
hydrophilic compound was mixed with liposomes by adding the

27. Texas Digital Sys., Inc. v. Telegenix, Inc., 308 F.3d 1193, 1202 (Fed. Cir. 2002).
28. Vitronics, 90 F.3d at 1582.
29. Id.
30. Pitney Bowes, Inc. v. Hewlett-Packard Co., 182 F.3d 1298, 1308 (Fed. Cir. 1999).
31. Id. While the order and method of consideration of the intrinsic evidence may be altered
by the Federal Circuit's eventual decision in Phillips v. AWH Corp., petition to rehear en banc
granted in 376 F.3d 1382 (Fed. Cir. 2004), it is probable that extrinsic evidence will remain a last
resort during claim construction. When a patent issues, the public is on notice as to the claims, and
the intrinsic evidence is fixed and available to the public, whereas extrinsic evidence may not be
available. Texas Digital, 308 F.3d at 1202-03.
32. See Liposome Co. v. Vestar, Inc., CIV.A.92-332-RRM, 1994 WL738952, at *9-*10 (D.
Del. Dec. 20, 1994). A liposome is a microscopic sphere or vesicle in which the membrane
surrounds an aqueous solution. Id. at * 1.
33. Id. at *1.
34. Id. at *13.
35. Id. at *12.
36. Id.
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hydrophilic compound to a colloidal dispersion of liposomes.3 7 According
to Vestar, this would result in the hydrophilic compound existing only on
the outside of the liposomes.38 Vestar argued that while prosecuting a
European counterpart to U.S. Patent No. 4,880,635, directed at the same
technology as the patent at issue, TLC read the claim language as meaning
adding the hydrophilic compound to liposomes.3 9 Based on these
inconsistent statements, Vestar sought to have TLC judicially estopped
from obtaining relief in the infringement suit.4
The district court rejected the notion that the inconsistent statements
could be used under the doctrine of judicial estoppel to prevent TLC from
arguing a construction of "mixing" that excluded "adding" because Vestar
could show no reliance on the statements made to the European Patent
Office (EPO).4 ' The district court instead found that these statements to the
EPO provided some evidence of how one skilled in the art would read the
words of the patent.4 2 The district court also agreed that the statements
could be relevant to show how TLC read the words of the claim at issue
when TLC was not seeking to enforce the claim in a court of law. 43 It
found that the claim term described a compound that was mixed with
existing liposomes, not with lipids that formed liposomes." The district
court based its decision primarily on the ordinary meaning of the "simple
and straight-forward" words in the claim, finding the prior statements
describing the claim "provid[ed] further evidence."45
The Southern District of New York also admitted statements made to
a foreign patent office during claim construction in a patent infringement
case involving U.S. Patent No. 4,135,202 for broadcasting systems with

37. Liposome Co., 1994 WL 738952, at *12.
38. Id. at *13.
39. Id. at *14.
40. Id.
41. Id. (citing Allen v. Zurich Ins. Co., 667 F.2d 1162, 1166(4th Cir. 1982); Hybritech Inc.
v. Abbott Lab., 849 F.2d 1446, 1453-54 (Fed. Cir. 1988)); but see Gallant v. Telebrands Corp., 35
F. Supp. 2d 378 (D.N.J. 1998). The Gallantcourt refused to let a patentee take a position in a U.S.
patent infringement suit that was contrary to a position taken before the EPO, reasoning, "[t]he
Plaintiffs, through their admissions to the European Patent Office, conceded the irrelevance of the
Quadraflex as prior art to Telebrands. The Plaintiffs cannot now assume a contrary position." Id.
at 400 (citing Tanabe Seiyaku Co. v. U.S. Int'l Trade Comm'n, 109 F.3d 726, 733 (Fed. Cir.), cert.
denied, 522 U.S. 1027 (1997); Merck & Co. v. Mylan Pharm., Inc., 19 F. Supp. 2d 334, 344 n.17
(E.D. Pa. 1998); Glaxo Wellcome, Inc. v. Pharmadyne Corp., 32 F. Supp. 2d 265, 290 (D. Md.
1998)).
42. Liposome Co., 1994 WL 738952, at *14.
43. Id.
44. Id. at "15.
45. Id.
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fiber optic transmission lines. 46 One term at issue during claim construction was "high frequency. 47 Defendants, UA-Columbia Cablevision
of Westchester, Inc. and Tele-Communications, Inc. (collectively UA),
asserted that "high frequency" must be limited to a range of 2 to 30 MHz. 8
One of their arguments in support of this assertion was that the inventor
told the Canadian Patent Office (CPO) during prosecution of a Canadian
counterpart patent that "high frequency" was limited to this range. 9
Plaintiff, Intellectual Property Development, Inc. (IPDI), argued that "high
frequency" should be construed as a range between 54 to 216 MHz. 50
The defendants' expert testified during claim construction that at the
time of the patent application, no conventional television receivers in the
United States operated in the range of 2 to 30 MHz. 1 Other evidence
suggested that the standard frequency for television receivers in the United
States operated in the VHF range of 30 to 300 MHz. 2 Judge Sotomayor
found the use of the term "conventional television receiver" in the claim
gave context and meaning to the term "high frequency," and therefore she
construed it as operating at least in a range of 54 to 216 IHz. 3 She noted
that statements in foreign counterpart prosecution histories may be
relevant to the state of the art at the time of patent application, but could
to change a natural reading and understanding of a claim in a
not be used
4
patent.1
After the Markman hearing, the case was reassigned to another judge
after Judge Sotomayor was elevated to the U.S. Court of Appeals for the
Second Circuit. 55 The action was transferred to a multi-district litigation

46. Intellectual Prop. Dev., Inc. v. UA-Columbia Cablevision of Westchester, Inc., No. 94
CIV. 6296 (SS), 1998 WL 142346 (S.D.N.Y. Mar. 26, 1998).
47. Id. at *3-*4.
48. Id. at "5.
49. Id. The other reason was that the inventor's employer, Rediffusion Companies
(Rediffusion), treated the patent as limited to this range. Id.
50. Id. This range falls within the Very High Frequency range (VHF) of 30 to 300 MHz. ld.
at *8.
51. Intellectual Prop. Dev., 1998 WL 142346, at *8.
52. Id.
53. Id.
54. Id. at *10 (citing Tanabe Seiyaku Co. v. U.S. Int'l Trade Comm'n, 109 F.3d 726 (Fed.
Cir.), cert. denied, 522 U.S. 1027 (1997); Markman v. Westview Instruments, Inc., 52 F.3d 967,
980-81 (Fed. Cir. 1995) (en banc), affid, 517 U.S. 370 (1996)). Even though Rediffusion acted as
though the patent covered the 3 to 30 MHz range, and Cutler informed the CPO that 3 to 30 MHz
was the range meant by "high frequency," Judge Sotomayor found that the meaning assigned to the
term by those of ordinary skill in the art controlled. Id. at *8.
55. Intellectual Prop. Dev., Inc. v. UA-Columbia Cablevision of Westchester, Inc., No. 94
CIV. 6296 (WHP), 2002 WL 10479, at *1 (S.D.N.Y. Jan. 3, 2002)
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consolidation in the Central District of California and then remanded back
to the Southern District of New York.56 After the remand, UA moved for
reconsideration of the Markman hearing in light of the discovery of new
documents relevant to the prosecution history and the Federal Circuit's
decisions in Festo Corp. v. Shoketsu Kinzoku Kogyo Kabuskiki Co. and
Pitney Bowes, Inc. v. Hewlett-PackardCo. 5 ' The district court granted the
motion, noting that the claim construction had occurred before the parties
completed their discovery.58
The district court reversed the original construction of the term "high
frequency., 59 The patentee had amended its first claim to include a range
of 40 to 300 MHz, but was forced to retract the amendment because the
specification could not support iti ° Furthermore, new extrinsic evidence
showed that the patentee had told its British patent agent that the range
was 3 to 30 MHz. 61 The patentee had also distinguished its patent from the
prior art based on a frequency range of 3 to 30 MHz.62 The district court
found that "high frequency" meant a range of 3 to 30 MZHz, after
considering these factors in light of the Federal Circuit decision in Pitney
Bowes.63
In AK Steel Corp. v. Sollac & Ugine,6'4 the Southern District of Ohio
considered whether statements to the EPO defining the term "consisting
essentially of aluminum" during patent prosecution should apply to the
claim construction of the same term in counterpart U.S. Patent No.
4,765,214 for a method of coating stainless steel. In the statements to the
EPO, the patentee defined the term as permitting "the presence of certain
elements or impurities in the coating metal of the aluminum bath such as
up to 2% iron but on the other hand, silicon contents in the coating metal
should not exceed about .5% by weight., 65 While noting that the term
"consisting essentially of' has a special meaning in U.S. claim drafting,
which made the European interpretation of the term "of little relevance,"
the district court agreed that the representations to the EPO should be

56. Id.

57. Id. at *4.
58. See id. at *5.
59. Id. at "13.
60. Intellectual Prop. Dev., 2002 WL 10479, at *11.
61. Id. at*12.
62. Id. at *10.
63. Id. at *10-13. The district court did not consider the Federal Circuit's decision in Festo
to be relevant to this analysis, since Festo dealt with prosecution history estoppel, not claim
construction. Id. at *6.
64. 234 F. Supp. 2d 711 (S.D. Ohio 2002).
65. Id. at 770.
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considered when "they comprise relevant evidence and are relevant to
claim construction of United States patents. 66
Judges have also denied motions to exclude evidence from foreign
prosecution histories during patent infringement litigations. In In re
CertainSortationSystems, the Administrative Law Judge (ALJ)denied a
motion to exclude the prosecution history of a European patent that was
a counterpart to U.S. Patent No. 5,127,5 10 for a modular diverter shoe and
slat construction, during the initial determination phase of a U.S.
International Trade Commission (Commission) investigation.67 The patent
assignee, Rapistan Systems, and exclusive licensee, Siemens Dematic,
(collectively Complainants) alleged Vanderlande Industries Nederland BV
and Vanderlande Industries (collectively Respondents) infringed the patent
by their manufacture and importation of certain sortation systems.68
The Complainants moved to exclude the prosecution history of a
counterpart European patent as irrelevant because it was not prior art to the
U.S. patent at issue. 69 The Respondents argued that statements to the EPO
during prosecution of this European counterpart were relevant to the
obviousness of the system and to the development timing of the sortation
system. 70 The Commission Investigative Staff argued that the statements
to the EPO were relevant to claim construction of the U.S. patent. 7 1 The
ALJ denied the motion to exclude the foreign prosecution history, agreeing
with the Staff and the Respondents that the prosecution history was
relevant to the validity and the claim construction of the patent at issue.72
The AUD noted that the Federal Circuit had not yet ruled on the issue of
using foreign prosecution histories for claim construction, but had
approved of their use when they comprise relevant evidence for analysis
under the doctrine of equivalents.73
66. Id. at 769-70 (citing Tanabe Seiyaku Co. v. U.S. Int'l Trade Comm'n, 109 F.3d 726,933
(Fed. Cir. 1997); Caterpillar Tractor Co. v. Berco, S.p.A., 714 F.2d 1110, 1116 (Fed. Cir. 1983)).
The representation to the EPO agreed with the special meaning assigned to the term by U.S. patent
practice. Id. at 770.
67. In re Certain Sortation Sys., U.S.I.T.C. Inv.No. 337-TA-460, 2002 WL 1492633, Admin.
Law Judge Order No. 36 (June 3, 2002).
68. In re Certain Sortation Sys., U.S.I.T.C., Inv.No. 337-TA-460, 2002 WL 1492665, Notice
of Violation (Mar. 2003).
69. Certain Sortation Sys., 2002 WL 1492633.
70. Id.
71. Id.
72. Id.
73. Id. (citing Tanabe Seiyaku Co. v. U.S. Int'l Trade Comm'n, 109 F.3d 726,933 (Fed. Cir.
1997); Caterpillar Tractor Co. v. Berco, S.p.A., 714 F.2d 1110, 1116 (Fed. Cir. 1983)). In 2004, the
Federal Circuit cautioned that the varying legal standards of patentability from country to country
might make consideration of certain representations inappropriate, but did not rule out use of these
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The Northern District of Illinois compelled production of
communications to foreignpatent agents in Baxter Travenol Laboratories,
74 Even if the communications themselves were
Inc. v. Abbot Laboratories.
inadmissible as protected by the attorney-client privilege, the district court
compelled production because the communications might lead to the
production of admissible evidence relevant to the claim construction or the
validity of the U.S. patent." The district court noted that the varying
standards of patentability from country to country meant the granting of
a foreign patent was not evidence of non-obviousness, but held that when
such instructions to foreign patent agents and representations to foreign
patent offices are relevant to the construction or validity of a U.S. patent,
they must be considered.76
3. Decisions in Which Evidence from a Foreign Prosecution History
was not Used to Aid in Claim Construction
Not all courts wholeheartedly approve of using foreign prosecution
histories during claim construction. For example, the Federal Circuit noted
in TI GroupAutomotive Systems v. VDO North America, L.L. C. that "'the
varying legal and procedural requirements for obtaining patent protection
in foreign countries might render consideration of certain types of
representations inappropriate' for consideration in a claim construction
analysis of a United States counterpart. 77 The Federal Circuit based its
affirmation of the district court's claim construction on the dictionary
definitions of the term, and declined to comment on the alleged infringer's
arguments that statements made by the patentee during prosecution of the
Japanese counterpart supported the district court's construction.78 The
Federal Circuit did not, however, completely rule out using representations
made to foreign patent offices in the claim construction context.7 9

representations. TI Group Auto. Sys. v. VDO N. Am., 375 F.3d 1126, 1136 (Fed. Cir. 2004); see
infra Part III.A.3.
74. Baxter Travenol Labs., Inc. v. Abbot Labs., No. 84 C 5103, 1987 WL 12919 (N.D. Ill.
June 19, 1987).
75. Id. at *7.
76. Id. (citing Caterpillar Tractor Co. v. Berco, S.p.A., 714 F.2d 1110, 1116 (Fed. Cir. 1983);
FED. R. Civ. P. 26(b)(1)). Whether the documents were protected by the attorney client privilege
depended on the laws of the foreign country. Id. at *8.
77. TI Group Auto. Sys., 375 F.3d at 1136 (quoting CaterpillarTractor Co., 714 F.2d at
1116).
78. Id.
79. Id.
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The Southern District of New York ruled in Astra Aktiebolag v. Andrx
Pharmaceuticals, Inc.8 that foreign prosecution histories were
inadmissible during claim construction. The district court rejected the use
of foreign prosecution histories during claim construction for two
reasons. 8 First, the defendants had "not even tried to lay a foundation for
its argument that foreign prosecutions should be considered on an issue of
United States law ...."82 Furthermore, while conceding that a foreign
prosecution history might be relevant to an infringement analysis under the
doctrine of equivalents, the district court distinguished claim construction
from such an analysis because the doctrine of equivalents is a question of
fact and claim construction is a matter of law.83
4. Proper Use of a Foreign Prosecution History During Claim
Construction of a Counterpart U.S. Patent
The claim construction process allows consideration of extrinsic
evidence to ensure a potential claim construction is consistent with the
understanding of one of skill in the art. 84 Extrinsic evidence may only be
relied upon if the meaning of the claims is still ambiguous after
consideration of all intrinsic evidence, including the words of the claims
themselves, the specification and the prosecution history. 5 If extrinsic
evidence must be considered to resolve the meanings of the claim terms,
it is reasonable to consider representations made to foreign patent offices
as extrinsic evidence, in addition to other extrinsic evidence such as expert
testimony. As many courts have noted, these representations can give
insight not only into the inventor's meaning of the claim terms at the time
of application but, more importantly, insight into how a person of ordinary
skill in the art would view the terms.86 If made prior to the patent litigation

80. 222 F. Supp. 2d 423, 466 (S.D.N.Y. 2002).
81. Id.

82. Id. (citing Heidelberger Druckmaschinen AG v. Hantscho Commercial Prods. Inc., 21
F.3d 1068, 1072 n.2 (Fed. Cir. 1994); Medtronic, Inc. v. Daig Corp., 789 F.2d 903, 907-08 (Fed.

Cir. 1986)).
83. Id. (citing Tanabe Seiyaku Co. v. U.S. Int'l Trade Comm'n, 109 F.3d 726,933 (Fed. Cir.
1997); Caterpillar Tractor Co. v. Berco, S.p.A., 714 F.2d 1110, 1116 (Fed. Cir. 1983)). See infra

Part III.B (discussing the use of foreign prosecution histories during an infringement analysis under
the doctrine of equivalents). The district court also noted that the representations to foreign patent
offices failed to support the defendant's position. Astra Aktiebolag, 222 F. Supp. 2d at 466.
84. Pitney Bowes, Inc. v. Hewlett-Packard Co., 182 F.3d 1298, 1309 (Fed. Cir. 1999).
85. Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1583 (Fed. Cir. 1996).

86. Intellectual Prop. Dev., Inc. v. UA-Columbia Cablevision of Westchester, Inc., No. 94
CIV. 6296 (WHP), 2002 WL 10479 (S.D.N.Y. Jan. 3, 2002); Liposome Co., Inc. v. Vestar, Inc.,
CIV.A.92-332-RRM, 1994 WL 738952 (D. Del. Dec. 20, 1994).
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and during the time period of the U.S. application, the statements made
during foreign patent prosecution may even provide a more balanced view
of the state of the art than expert testimony at trial.
One question that remains is what aspects of the foreign prosecution
history should be considered during litigation of a counterpart U.S. patent.
To date, courts have only used representations from a foreign prosecution
history. This trend should continue. Representations made to foreign
patent offices during patent prosecution are more easily interpreted by a
court than amendments made during the foreign prosecution process.
Furthermore, an inquiry into a response from a foreign examiner may be
less related to a foreign standard of patentability than an amendment to
satisfy the foreign standards of patentability. For this reason, while
representations made by the patentee could be considered during claim
construction of a counterpart U.S. patent, foreign amendments should
rarely, if ever, be considered.
Courts have not allowed representations made to foreign patent offices
to override the clear and unambiguous meaning of a claim term. Rather,
they have been treated as yet another piece of extrinsic evidence. If the
proper claim construction process is followed, representations made to
foreign patent offices can be used as extrinsi c evidence to verify a claim
construction. They can also be used as extrinsic evidence (in addition to
other extrinsic evidence such as expert testimony) when the claim terms
are still ambiguous. As long as a court keeps in mind that the
representations made to a foreign patent office may be unrelated to the
patentability of the invention in the United States, the representations may
aid in claim construction.
B. Foreign ProsecutionHistory and ProsecutionHistory Estoppel
Representations made to foreign patent offices during foreign patent
prosecution have also been used to estop a patentee from relying on the
doctrine of equivalents during litigation of a counterpart U.S. patent.
1. The Doctrine of Equivalents and Prosecution History Estoppel
The doctrine of equivalents is a judicially created doctrine providing
that the scope of a patent is not limited to its literal terms, but instead
embraces all equivalents to the claims. 87 The purpose of the doctrine of
equivalents is to protect a patent holder against copyists attempting to

87. Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 535 U.S. 722,732 (2002) (citing
Winans v. Denmead, 56 U.S. (15 How.) 330, 347 (1854)).

JOURNAL OF TECHNOLOGY LAW& POLICY

[Vol. 10

escape liability for infringement by making only insubstantial changes to
a patented invention.8 The premise underlying the doctrine is that it is
impossible for language to capture every nuance of a patent or describe its
scope with complete precision.89
Because the doctrine of equivalents renders the scope of a patent less
clear than the literal scope of the patent, courts use the doctrine of
prosecution history estoppel as a check on the doctrine of equivalents. 9°
Prosecution history estoppel, or file wrapper estoppel, is the requirement
that claims of a patent be interpreted in light of the proceedings in the U.S.
Patent and Trademark Office (USPTO) during the application process. 91
The doctrine prevents a patentee from recapturing subject matter
surrendered during patent prosecution in a subsequent litigation
proceeding. 92 It prevents a patentee who narrowed the scope of her
coverage during patent prosecution from reclaiming the disclaimed subject
matter as an equivalent.93 Whether prosecution history applies to an
equivalent is a matter of law.94
If the patentee makes a narrowing amendment to satisfy any provision
of the Patent Act, a presumption arises that the patentee surrendered all
territory between the original claim limitation and the amended claim
limitation.95 The patentee may rebut this presumption of complete
surrender by showing it did not surrender the particular equivalent in
question in one of three ways.96 The patentee may show that the equivalent
was unforeseeable at the time of the amendment, that the reason for the
amendment was only tangentially related to the equivalent in question, or
that for "some other reason," the patentee could not have described the

88. Festo, 535 U.S. at 726.
89. Id. at 731.
90. Id. at 727, 733-34; AM. JuR. Patents § 789 (2004) ("File wrapper or prosecution history
estoppel, if established, supersedes or limits a patentee's reliance on the doctrine of equivalents.
Thus, prosecution history estoppel is a legal limitation on the doctrine of equivalents."). The
doctrine of equivalents, by expanding the coverage of the patent beyond its literal claims, makes
it difficult for competitors to determine what will infringe an invention and what is a non-infringing
alternative. Festo, 535 U.S. at 727.
91. Festo, 535 U.S. at 733.
92. Id. at 734.
93. Id.
94. Smithkline Beecham Corp. v. Excel Pharm., Inc., 356 F.3d 1357 (Fed. Cir. 2004).
95. Festo, 535 U.S. at 736-38; Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 344
F.3d 1359, 1365 (Fed. Cir. 2003).
96. Festo, 535 U.S. at 740-41.

2005]

PATENTLY IRRELEVANT? USE OF FOREIGN PROSECUTION HISTORYAS EXTRINSIC EVIDENCE

15

equivalent in question. If the patentee can rebut this presumption, then
prosecution history will not apply to the equivalent. 98
When determining whether an alleged equivalent was unforeseeable,
a court may consider expert testimony and extrinsic evidence. 99 Proof of
a tangential relationship between the reason for amendment and the
alleged equivalent is restricted to the prosecution history, except when
expert testimony from those skilled in the art is required to interpret that
record. 00 Determination of whether there is some other reason why the
equivalent could not be described should be restricted to the prosecution
history "[w]hen at all possible."'' 1
2. Decisions in Which Evidence from a Foreign Prosecution
History was Used to Limit the Scope of Equivalents
The Federal Circuit first considered the effect of representations made
to a foreign patent office on the scope of equivalents available to a
patentee in CaterpillarTractorCorp. v. Berco, S.p.A. Caterpillar Tractor
Corp. (Caterpillar) held U.S. Patent No. 3,841,718 for a crescent seal for
tractors. 10 2 There was no literal infringement, so Caterpillar had to rely
upon the doctrine of equivalents to prove infringement. 0 3 Berco S.p.A.
(Berco), the alleged infringer, cited representations made by Caterpillar to
the Great Britain and German patent offices and to Caterpillar's foreign
associates when prosecuting counterpart applications, as evidence that the
equivalent embodiment was not contemplated by Caterpillar.' 4
The Federal Circuit noted that no authority was cited for the
proposition that instructions to foreign patent counsel and representations
to foreign patent offices should be considered. 10 5 The court also
acknowledged that varying legal and procedural requirements for
obtaining patents in foreign countries may render consideration of certain
types of representations inappropriate. 106 Despite these caveats, the Federal
Circuit held that when such matters "comprise relevant evidence they must

97.
98.
99.
100.
101.
102.
103.
104.
105.
106.

Id.
Id.
Festo, 344 F.3d at 1369.
Id. at 1369-70.
Id. at 1370.
Caterpillar Tractor Co. v. Berco, S.p.A., 714 F.2d 1110, 1111-12 (Fed. Cir. 1983).
Id. at 1115.
Id. at 1116.
Id.
Id.
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be considered." 10 7 Even though the representations showed that the
equivalent embodiment had not been considered at the time the application
was filed, this was not a basis for denying application of the doctrine of
equivalents. 108
The U.S. International Trade Commission considered representations
made to foreign patent offices in a later case involving infringement of
U.S. Patent No. 4,438,035 for a process for producing diltiazem
hydrochloride held by Tanabe Seiyaku Co. (Tanabe).' 09 The patent recited
a chemical reaction known as an "N-alkylation" reaction to be performed
in the presence of a base-solvent combination. "0 Five specific base-solvent
combinations were disclosed in the patent and recited in the claim at
issue."' The alleged infringer was using a solvent not recited in the patent,
forcing Tanabe to rely upon the doctrine of equivalents at trial." 2
During the application process before the USPTO, Tanabe had
distinguished its patent from the prior art by claiming that the five basesolvent combinations provided high yields under safe and economical
conditions." 3 When prosecuting counterparts to the patent in Finland,
Israel, and before the EPO, Tanabe also argued that its process was
patentable because the five base-solvent combinations gave unexpectedly
better results than other combinations. 114 Based on the claim language and
the statements to foreign patent offices, the Commission found no
infringement under the doctrine of equivalents because Tanabe intended
to exclude all bases and solvents except those that were particularly
claimed, including those that would normally be equivalents." 5
On appeal to the Federal Circuit, Tanabe argued that the Commission
had erroneously invoked an estoppel against Tanabe regarding the proper
range of equivalents based in part upon the statements to the foreign patent

107. CaterpillarTractorCo., 714 F.2d at 1116 (citing Stratoflex, Inc. v. Aeroquip Corp., 713
F.2d 1530, 1538 (Fed. Cir. 1983)). The Stratoflex court said, "It is jurisprudentially inappropriate
to disregard any relevant evidence on any issue in any case, patent cases included," when
considering evidence of secondary considerations of obviousness. Stratoflex, 713 F.2d at 1538.
108. CaterpillarTractorCo., 714 F.2d at 1116.
109. Tanabe Seiyaku Co. v. U.S. Int'l Trade Comm'n, 109 F.3d 726, 727 (Fed. Cir. 1997).
110. Id. at 729.
111. Id.
112. Id.
113. Id. at730.
114, Tanabe Seiyaku Co., 109 F.3d at 730.
115. Id. at731.
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offices." 6 Relying on the decision in CaterpillarTractor Co., the Federal
Circuit held that in evaluating infringement under the doctrine of
equivalents, representations to foreign patent offices should be considered
when they offer relevant evidence. 117 The statements to foreign patent
offices that specific combinations of bases and solvents produced better
results and distinguishing the prior art based on these results were relevant
to the determination of whether a person skilled in the art would consider
another solvent interchangeable with the claimed solvents in Tanabe's
claimed process. 8 In affirming the Commission's finding, the Federal
Circuit relied upon the claim language, the U.S. prosecution history, and
the statements made to the foreign patent offices.' 19
In Merck & Co. v. Mylan Pharmaceuticals,Inc., the Eastern District of
Pennsylvania found instructions given by Merck & Co. (Merck) to the
New Zealand Patent Office during prosecution of a foreign counterpart
patent to be "instructive" during analysis under the doctrine of
equivalents. 120 Merck brought an action against Mylan Pharmaceuticals
(Mylan) for infringement of two patents for a drug used to treat
Parkinson's disease.121 In response to Merck's infringement action, Mylan
argued that the prosecution history of Merck's patents precluded Merck
from obtaining coverage of Mylan's generic formulation. 122 Merck's
hypothetical claim, 2 3 developed as the first step in analyzing an asserted
limitation on use of the doctrine of equivalents through the prior art,
24
included the element that the claimed oral dosing tablet was nonfloating.1
Merck needed the nonfloating element to avoid a prior art restriction on
equivalency because the tablets shown in the25 prior art floated and neither
Merck's nor Mylan's formulations floated.1
116. Id. The court rejected Tanabe's argument that use of such statements constituted a
"foreign prosecution [history] estoppel" to limit the application of the doctrine of equivalents. Id.
at 733.
117. Id.
118. Id.
119. Tanabe Seiyaku Co., 109 F.3d at 731.
120. Merck & Co., Inc. v. Mylan Pharm., Inc., 19 F. Supp. 2d 334, 344 n.17 (E.D. Pa. 1998).
121. Id. at 336.
122. Id. at 340-41.
123. Id. at 342-43. ("[T]he first step in analyzing an asserted limitation on use of the doctrine
of equivalents through the prior art is development of a proper hypothetical claim. Such a
hypothetical should be structured to be similar to the patentee's claims, but broad enough to
literally cover the accused's device." (citing Wilson Sporting Goods Co. v. David Geoffrey &
Assocs., 904 F.2d 677, 685 (Fed. Cir. 1990))).
124. Id. at 343.
125. Merck & Co., 19 F. Supp. 2d at 341 (citations omitted) ("The prior art restricts the scope
of equivalency that the party alleging infringement under the doctrine of equivalents can assert.").
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In response, Mylan argued that because neither the Merck nor Mylan
formulations placed a limitation on the ability of the tablet to float, the
hypothetical claim could not contain a nonfloating limitation.1 26 Merck's
prosecution history revealed that Merck never attempted to distinguish
prior art by using a floating/nonfloating distinction but instead
distinguished the prior art based on the polymers.127 Although Merck's
statements to the New Zealand Patent Office that distinguished the prior
art were not preclusive, the district court considered them "instructive"
with regard to the floating/nonfloating limitation and declined to include
a nonfloating limitation based on the U.S. prosecution history, 28
the prior
Office.1
Patent
Zealand
New
the
to
made
statements
art, and the
3. Proper use of a Foreign Prosecution History During Analysis Under
the Doctrine of Equivalents of a Counterpart U.S. Patent
Evidence from the foreign prosecution history can be used in several
ways to determine whether prosecution history estoppel applies to the
equivalent in question. First, it can be used to determine whether an
equivalent was foreseeable at the time of narrowing amendment. 129 For
example, if the patentee seeks to recapture an equivalent that was
discussed during foreign patent prosecution, the foreign prosecution
history could be used to show that the equivalent was foreseeable at the
time of the amendment to the U.S. application.
Presently, the patentee may resort only to the U.S. prosecution history
to show that the amendment to the U.S. application was made for a reason
only tangentially related to the equivalent in question. 130 The rationale for
this limitation is that the patent itself and its prosecution history, both
available to the public, have a public notice function. 131 It would be unfair
to allow the public to rely on this available information and then allow the
126. Id.
127. Id.
128. Id. at 244 n. 17. Merck did tell the New Zealand Patent Office that the Sheth formulation
was designed to float on gastric fluids while their contents were slowly released and that the
mechanism that resulted in floating was very different than the Merck mechanism. Id. However,
Merck chose to restrict the claims by limiting the polymers used and not basing them on the
floating/nonfloating distinction. Id. The district court found this decision suggested that the
nonfloating characteristic was not a restriction on the invention. Id. at 345.
129. Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 344 F.3d 1359, 1369 (Fed. Cir.
2003) (holding that extrinsic evidence may be considered when determining whether an alleged
equivalent was unforeseeable). The time at which the representation was made to the foreign patent
office is clearly relevant to this determination.
130. Id.
131. Id.
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patentee to 32
recapture an equivalent by using information not available to
the public. 1
Expert testimony is allowed, if necessary, to aid in the interpretation of
the prosecution history.1 33 It is also possible that the foreign prosecution
history could aid in that interpretation. After all, the use of foreign
prosecution history during claim construction has been justified on the
grounds that it aids in understanding how a person of ordinary skill in the
art would view a claim term. 34 On the other hand, given the fact that the
reason for amendment is likely found in the context which the amendment
was made (the U.S. prosecution history), the foreign
prosecution history
13
would probably be of little value in this analysis.
Finally, the foreign prosecution history could be used to determine if
there was "some other reason" the equivalent could not have been
described. While the evidence used in this determination is restricted to the
U.S. prosecution history "[w]hen at all possible," the Federal Circuit has
not ruled out the use of other evidence. 136 As with the issue of
foreseeability, the foreign prosecution history could be used to show that
the "some other reason" does not exist for the equivalent in question.
There are several reasons why courts should continue to restrict use of
a foreign prosecution history to representations made to the foreign patent
office when determining the scope of equivalents available to a patentee.
First, as in claim construction, clear representations made to foreign patent
offices during patent prosecution are more easily interpreted for the
purposes of determining the scope of equivalents available than
amendments made during the foreign prosecution process.
Claim amendments made in response to a foreign patentability
requirement also may not be relevant to the equivalent at issue. It is
certainly a more daunting proposition to evaluate amendments made to
foreign patent applications and determine if the amendment was made for
a reason related to the foreign standard of patentability, a U.S. standard of
patentability, or the standards of both countries, compared to evaluating
a statement by a patentee. Even if the reason for amendment was
applicable to a U.S. standard of patentability, should the patentee still lose
access to that equivalent if the amendment was not made to obtain the U.S.

132. Id.
133. Id.
134. Intellectual Prop. Dev., Inc. v. UA-Columbia Cablevision of Westchester, Inc., 2002 WL
10479 (S.D.N.Y. Jan. 3, 2002); Liposome Co. v. Vestar, Inc., 1994 WL 738952 (D. Del. Dec. 20,
1994).
135. Festo, 344 F.3d at 1369.
136. Id.
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patent? Such an analysis could give rise to a doctrine of foreign
prosecution history estoppel rejected by the Federal Circuit in Tanabe
Seiyaku Co. 13 7 For these reasons, amendments to foreign patent
applications should rarely, if ever, be considered when determining the
scope of equivalents available to a patentee.

IV. CONCLUSION

Concerns about the varying standards of patentability from country to
country have prevented some courts from admitting evidence from a
foreign patent's prosecution history during the litigation of a counterpart
U.S. patent. These concerns, while valid, should not result in a wholesale
refusal to admit such evidence. Representations made by the patentee
during the application process can be relevant to the issues of claim
construction of the U.S. patent and the scope of equivalents available to
the patentee. Amendments made to the foreign patent, however, should be
used cautiously, if ever, because they are not as clear than statements made
by the patentee to the foreign patent office. Amendments may also be
more likely to have been made in response to a foreign standard of
patentability. Furthermore, use of such amendments runs close to a
doctrine of "foreign prosecution estoppel" rejected by the Federal Circuit.
Representations made to foreign patent offices can be used as extrinsic
evidence during claim construction. When these representations are
restricted to their proper place as extrinsic evidence, they can aid in claim
construction. They can be used to ensure the proposed construction is
consistent with the understanding of one skilled in the art. The
representations (and other extrinsic evidence) should only be relied upon
when the patent's intrinsic evidence leaves the meaning of the claim terms
ambiguous. The representations to foreign patent offices can also be used
to determine the scope of equivalents available to a patentee. Such
representations may aid a court in determining whether the equivalent at
issue was foreseeable at the time of amendment to the U.S. patent, or if
there was some other reason the equivalent could not have been described
at the time of amendment.
Representations to foreign patent offices during patent prosecution can
play a critical role during the claim construction or infringement analysis
under the doctrine of equivalents of a counterpart U.S. patent. Courts
should consider such representations when they are relevant to the
litigation and in a manner consistent with the existing laws of claim

137. Tanabe Seiyaku Co., 109 F.3d 726, 733 (Fed. Cir. 1997).
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construction and prosecution history estoppel. By considering
representations to foreign patent offices, courts can consider all of the
available and relevant evidence-to make their determinations.

22
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